More about

Genitourinary Cancer

News
February 21, 2023
4 min read
Save

Healio | HemOnc Today announces new physician leadership

Healio | HemOnc Today is excited to announce a new physician leadership structure, which features seven Associate Medical Editors from various subspecialty areas within oncology and hematology.

News
January 22, 2023
1 min read
Save

Thomas Jefferson University appoints chair of medical oncology

Thomas Jefferson University appoints chair of medical oncology

William Kevin Kelly, DO, has been appointed chair of the department of medical oncology for Sidney Kimmel Medical College at Thomas Jefferson University.

News
December 16, 2022
1 min read
Save

FDA approves gene therapy for high-risk non-muscle invasive bladder cancer treatment

FDA approves gene therapy for high-risk non-muscle invasive bladder cancer treatment

The FDA has approved a gene therapy treatment for adult patients with high-risk bacillus Calmette-Guérin unresponsive non-muscle invasive bladder cancer with carcinoma in situ with or without papillary tumors, according to a press release.

News
September 27, 2022
3 min watch
Save

Sugar-sweetened beverages linked to cancer mortality risk

Sugar-sweetened beverages linked to cancer mortality risk

Consumption of sugar-sweetened beverages appeared associated with increased risk for death from an obesity-related cancer, according to study results published in Cancer Epidemiology, Biomarkers & Prevention.

News
August 04, 2022
2 min read
Save

Modern guidelines improve late relapse rates, outcomes in testicular cancer

Modern guidelines improve late relapse rates, outcomes in testicular cancer

CHICAGO — Centralized treatment and adherence to modern guidelines may account for “relatively low” rates of late relapse and improved long-term outcomes after treatment for testicular cancer, according to a speaker at ASCO.

News
July 26, 2022
2 min read
Save

Savolitinib not significantly efficacious in advanced clear cell renal cancer

Savolitinib not significantly efficacious in advanced clear cell renal cancer

CHICAGO — Savolitinib, alone or in combination with durvalumab, did not demonstrate significant efficacy in patients with advanced clear cell renal cancer, according to a presentation at ASCO Annual Meeting.

News
July 22, 2022
1 min read
Save

Cabozantinib did not extend survival in patients with metastatic urothelial carcinoma

CHICAGO —Cabozantinib did not significantly extend progression-free survival in patients with metastatic urothelial carcinoma who had undergone platinum-based chemotherapy, according to data presented at ASCO Annual Meeting.

News
July 11, 2022
1 min read
Save

FDA grants fast track designation to abelacimab for cancer-associated thrombosis

The FDA granted fast track designation to abelacimab for treatment of cancer-associated thrombosis, according to a press release from the agent’s manufacturer.

News
May 18, 2022
4 min read
Save

Fox Chase Deputy Director: ‘Let every opportunity for change be one for progress’

Fox Chase Deputy Director: ‘Let every opportunity for change be one for progress’

Elizabeth R. Plimack, MD, MS, was recently named deputy director of Fox Chase Cancer Center and will oversee clinical and translational research plans as part of her goal to support new cancer care initiatives at the center.

News
May 17, 2022
2 min read
Save

Surveillance testing, treatment may be overused in low-risk bladder cancer subgroup

Surveillance testing, treatment may be overused in low-risk bladder cancer subgroup

Efforts to limit overuse of surveillance testing and treatment for low-risk nonmuscle-invasive bladder cancer are needed to alleviate increasing costs of care, results of a population-based cohort study suggested.

View more